Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial
Authors:
- M. CreusMCM. Creus
- F. FabreguesFFF. Fabregues
- F. CarmonaFCF. Carmona
- S. Martinez-RomanSMS. Martinez-Roman
- D. ManauDMD. Manau
- J. A. VanrellJVJ. A. Vanrell
Open Access
- 1 September 1997
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 12 (9) , 2046-2050
Abstract
The present study is the first prospective randomized controlled trial of the effect of pentoxifylline on future fertility in infertile women with asymptomatic minimal or mild endometriosis. After completion of a basic infertility workup and laparoscopy, patients were entered into the study and randomly allocated to receive either a 12 month course of oral pentoxifylline (800 mg/day) (n = 30) or an oral placebo (n = 30). Those patients with other infertility factors were included in the study only if the factors were correctable and ultimately determined to be non-contributory. Life-table analysis was used to compare pregnancy rates between the two groups over a 12 month period that started immediately after laparoscopy. The 12 month actuarial overall pregnancy rates were 31 and 18.5% in the pentoxifylline and placebo groups respectively. However, this difference was not statistically significant by the chi(2)-test. Similarly, the Cox regression method showed no differences between the hazard of pregnancy in the two groups studied (odds ratio, 0.56; 95% confidence interval, 0.18-1.67). Therefore, there is no evidence from this study that immunomodulation with pentoxifylline aids fertility in those women with minimal or mild endometriosis. Further studies including more infertile patients with endometriosis are desirable in order to confirm our results.Keywords
This publication has 12 references indexed in Scilit:
- Immunological factors in endometriosis-associated reproductive failure: studies in fertile and infertile women with and without endometriosisHuman Reproduction, 1997
- The peritoneal environment in endometriosisHuman Reproduction Update, 1996
- An argument for the past and continued use of pentoxifylline in assisted reproductive technologyHuman Reproduction, 1995
- Pentoxifylline in idiopathic male-factor infertility: a review of its therapeutic efficacy after oral administrationHuman Reproduction, 1994
- Peritoneal fluid: its relevance to the development of endometriosisFertility and Sterility, 1993
- Immunomodulation in the treatment of endometriosis-associated subfertility: use of pentoxifylline to reverse the inhibition of fertilization by surgically induced endometriosis a rodent modelFertility and Sterility, 1991
- Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model: a paradigm for a novel approach to the treatment of endometriosis-associated subfertilityFertility and Sterility, 1991
- Pathophysiology of mild endometriosis: review of literatureHuman Reproduction, 1990
- Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosisFertility and Sterility, 1988
- The effectiveness of danazol on subsequent fertility in minimal endometriosisFertility and Sterility, 1982